SlideShare a Scribd company logo
1 of 36
+
DIABETIC FOOT - CASE REPORT
DIVISI ENDOKRIN METABOLIK
BAGIAN ILMU PENYAKIT DALAM
UNIVERSITAS HASANUDDIN
+
Case
 Name : Ny. M
 Date of birth : 12-04-1969 / 40 years old
 Gender : Female
 Marital status : Married
 Religion : Muslim
 Address : Benteng, Wara
Timur
 Medical Record Number : 010430
 Date of Admission : 28-10-
2019
+ History Taking
The patient notice a spontaneous small opening and redness without any external
injury on the dorsal and plantar aspect of left foot 2 weeks prior to admission.
Wound was painfull, swelling and spreading. Currently there is mild discharge on
the wound without foul smell. History of intermittent fever, nausea, vomiting, cough,
difficulty in breathing and sleeplessness was present.
There was history of amputation of little finger of the left hand a year ago due to
ischemic and heel of right foot in 2012.
Chief complaint: Injury of left foot
+ History Taking
 She was diagnosed with Type 2 Diabetes Mellitus 10 years ago,
uncontrol.
 There’s no history and current impaired vision,
 She was diagnosed with hyperurecemia, uncontrol.
 The patient denied any history of heart disease, hypertention,
hypercholestrolemia.
 There is no history of cigarette smoking.
+
Patient Status
General condition : Moderate Illness/Compos Mentis (E4M6V5)
Height : 159 cm
Weight : 53 kg
BMI : 23.34 kg/m2
Vital Sign
Blood pressure : 120/70 mmHg Heart rate : 75 x/minutes
Respiratory rate : 18 x/minutes Temperature : 37,3 ‘C
Physical Examination
+
Physical Examination
Head
• Shape : Normocephal
•Face : Symmetrical left = right
•Deformity : -
Eye
• Eksoptalmus/Enoptalmus : (-)
• Movement : In normal range
• Eyelid : Edema palpebra (-)
• Conjungtiva : anemis
• Sclera : Ikterik (-)
• Cornea : Clear
• Pupil : Isochore Φ2,5
mm/2,5 mm
Ear
• Hearing : In normal range
• hemorrhage (-), Otorrhea (-)
 Nose
• Epistaxis : (-)
• Nasal Discharge : (-)
Mouth
• Lip : Cyanosis (-), Dry (-)
• Teeth : Dental caries (-)
• Gumes : Bleeding gum (-)
• Tonsil : T1 – T1, hyperemia (-)
• Pharynx : Hiperemis (-)
• Tongue : Dirty (-), Tremor(-), Hyperemia(-)
+
Physical Examination
Neck
Lymph nodes : Enlargement (-)
Thyroid Gland : Enlargement (-)
JVP : R+ 2 cm H2O
Blood Vessels : In normal Range
Nuchal Rigidity : Negatif
Tumor : Negatif
Trachea : Deviation (-)
Toraks
Inspection : Symetrical left = right
Palpation : mass (-), vocal fremitus is
normal
Percussion: Sonor
Auscultation: breath sound : vesicular. Ronchi and
wheezing (-)
+
Physical Examination
Cor
Inspection: Ictus cordis isn’t visible
Palpation : Ictus cordis isn’t palpable, Thrill (-),
Tenderness (-)
Percussion :
Right Upper border 2nd ICS linea parasternalis dextra
Left Upper border 3th ICS llinea parasternalis sinistra
Right lower border 4th ICS linea parasternalis dextra
Left lower border 6th ICS linea axillaris anterior sinistra
Auscultation: Heart sound I/II pure regular, murmur (-
)
Abdomen
Inspection : convex, following breath
movement
Auscultation: Peristaltic sound (+),
normal
Palpation : Mass (-), tenderness (-),
there are no palpable
Percussion : Timpani (+), ascites (-)
+
Physical Examination
Lower extremities
Inspection : Ulcer on the left little toe 1x1cm.
Gangrene on the left fourth and little toes
(plantar pedis). Pus (-) , blood (-).
Palpation : Tenderness
Upper extremities
Inspection : Amputated left little finger.
Palpation : Tenderness (-)
+
+ Laboratorium (08/05/2019)
Examination Result Normal value
RBC 2,28 (106/ mm3) F: 4.00 - 5.50 106/ mm3
M: 5.00 - 5.80 106/ mm3
HGB 6.9 (g/dL) 12.0 - 16.0 g/dL
MCV 87.3 fL 80,0 – 97,0 Fl
MCH 30.3 Pg 26.5 – 33,5 pg
MCHC 34.7 (g/dL) 31.5 - 35.0 g/dL
WBC 19.60 (103/uL) 4.00 - 10.0 103/uL
NEUT 86.6 % 52.0 - 75.0 %
LYMP 8.8 % 20.0 - 40.0 %
PLT 375 (103/uL) 150 - 450 103/uL
GDS 523 <140 mg/dL
+ Laboratorium (08/05/2019)
Examination Result Normal Value
RBC 2.66 (106/ mm3) F: 4.00 - 5.50 106/ mm3
M: 5.00 - 5.80 106/ mm3
HGB 8.1 (g/dL) 12.0 - 16.0 g/dL
MCV 88.7 fL 80,0 – 97,0 fL
MCH 30.5 Pg 26.5 – 33,5 pg
MCHC 34.3 (g/dL) 31.5 - 35.0 g/dL
WBC 22.16 (103/uL) 4.00 - 10.0 103/uL
NEUT 84.1 % 52.0 - 75.0 %
LYMP 8.8 % 20.0 - 40.0 %
MONO 6.2 % 2.0 - 8.0 %
EOS 0.8 % 1,00– 3.00%
BASO 0.1 % 0.0 - 0.10 %
HCT 23.6 % 37.0 - 48.0 %
PLT 357 (103/uL) 150 - 450 103/uL
+
Examination Result Normal value
GDS 350 <140 mg/dL
SGPT 21 <41
SGOT 15 <38 U/L
Albumin - 3,5-5,0 gr/dl
Kreatinin 1.5 M<1,3; F<1,1
Ureum 33 10-50 mg/dl
Natrium 136 136-145
Kalium 4.3 3,5-5,1
Klorida 106 97-111
PT 15.5 10-14 Second
INR 1.3 --
APTT 26.4 22,0-30,0 Second
Assesment
1. Diabetic Foot wagner IV Pedis Sinistra
2. Diabetes Militus Type 2 Non Obest
3. Anemia Normocytic Normochrome
4. Diabetic Gastropathy
Therapy
• Infusion NaCl 0,9% 30 TPM
• Novorapid 18-18-18 sc
• Levemir 0-0-20 sc
• Paracetamol 1g/8 Hour/Intravena
• Ciprofloxacin 500mg/8 Hour/Intraven
• Metronidazole 500g/8 Hour/ Intraven
• Ceftriaxon 2gr/24hour/Intraven
• Transfusion PRC 1 Bag
• Omeprazole 20mg /12 Hour/Oral
• Domperidone 10mg/8 hours/oral
Planning
• Blood Glucose Monitoring
• Diet (Diet DM 1700 kkal)
• Wound control
• Radiology : X-ray pedis
DISCUSSION
Definition
• Diabetic foot is one of the most significant and devastating complications of
diabetes, and is defined as a foot affected by ulceration that is associated with
neuropathy and/or peripheral arterial disease of the lower limb in a patient with
diabetes.
Epidemiology
• Systematic review included a large sample of studies involving more than 800,000 global participants from
67 studies in the past three decades. These studies included patients from five continents.suggested that
the pooled prevalence of diabetic foot ulceration was about 6.3% worldwide
• The results suggested that the highest prevalence of diabetic foot ulceration was reported in North Americ
(13.0%), and the lowest prevalence was reported in Oceania (3.0%). The prevalence of diabetic foot ulcer
was relatively higher in Africa (7.2%) than in Asia (5.5%) and Europe (5.1%).
Zhang, P., 2017. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Annals of Medicine, 1, 1.
Clinical Manifestasions
Clinical manifestations of DM are associated
with the metabolic consequences of insulin
deficiency:
• Fasting sugar levels are not normal.
• Poliuria
• Polidipsia
• Polifagia
• Weight Loss
• Tired and sleepy
• Other symptoms that are complained of are tingling,
itching, blurred eyes, impotence in men, and prurity vulva
in women.
In addition, there are other
clinical symptoms that show
more signs of ulcers due to
microangiopathy in people with
diabetes mellitus, which is 5P
which means:
a. Pain(nyeri)
b. Paleness(kepucatan)
c. Paresthesia (kesemutan)
d. Pulselessness (denyut nadi
hilang)
e. Paralysis (kelumpuhan)
Clinical Symptoms
Etiology &
Pathophysiology
Diagnosis
Diagnosis
Diagnosis
The nylon monofilament test is a
simply performed office test to
diagnose patients at risk for
ulcer formation due to
peripheral sensory neuropathy.
The test is abnormal if the patient
cannot sense the touch of the
monofilament when it is pressed
against the foot with just enough
pressure to bend the filament
DM Therapy: Non Pharmacology
•The course of the disease, the need for ongoing control and monitoring
DM complications, risk factors, non-pharmacological interventions,
pharmacological, and treatment targets
How to monitor blood glucose and interpret the results, recognize early
symptoms and manage hypoglycemia
The importance of foot care and regular physical exercise
Education
•Cannot walk barefoot
Check the foot every day, report to the doctor for skin peeling, redness, or
sores
Check footwear from foreign objects before use
Keep feet clean
Cut nails regularly
Dry regularly after the bathroom
Use cotton socks
Thin the callus regularly
Use custom made footwear
Feet Care
DM Therapy: Non Pharmacology
KARBOHIDRAT
•Karbohidrat: 45-
65%, berserat
tinggi, tidak boleh
& 130 g
•Glukosa dalam
bumbu masih
diperbolehkan
•Sukrosa &amp;lt;
5%
•Pemanis alternatif
•Makan tiga kali
sehari + selingan
LEMAK
•20-25% (Lemak
jenuh & 7%; lemak
tidak jenuh ganda
&amp;lt; 10%;
selebihnya lemak
tidak jenuh
tunggal)
•Batasi daging
berlemak dan
susu fullcream
(lemak trans)
•Konsumsi
kolesterol &200
mg/hari
PROTEIN
•10-20%
•Nefropati diabetik:
10% atau 0.8
g/kgBB dengan
65% diantaranya
bernilai biologik
tinggi
•Penderita DM
yang menjalani
HD: 1-1.2
g/kgBB/hari
NATRIUM
•2300 mg/hari
SERAT
•20-35 g/hari
•Kacang-kacangan,
buah, dan
sayuran,
karbohidrat tinggi
serat
PEMANIS
ALTERNATIF
•Berkalori: Hitung
kandungan
kalorinya (isomalt,
lactitol, maltitol,
mannitol, sorbitol,
xylitol)
•Fruktosa tidak
dianjurkan
Meningkatkan
kadar LDL.
Namun tidak ada
alasan
menghindari
makanan seperti
buah/sayur karena
mengandung
fruktosa alami
•Tak berkalori:
Aspartam, sakarin,
acesulfame
potassium,
sukralose,
neotame
DM Therapy: Non Pharmacology
• 3-5 kali per minggu
• 30-45 menit (total 150 menit per minggu)
• Jeda antar latihan tidak lebih dari 2 hari berturut-turut
• GDS &amp;lt; 100 mg/dl Konsumsi karbohidrat terlebih
dahulu
• GDS &amp;gt; 250 mg/dl Tunda olahraga
• Latihan jasmani bersifat aerobik
• Intensitas sedang
• Jalan cepat
• Bersepeda santai
• Jogging
• Berenang
• DM tanpa kontraindikasi (OA, HT tidak terkontrol,
retinopati, nefropati)
• Resistance training (latihan beban) 2-3 kali/minggu
Exercise
DM Therapy
DM Therapy
Dosis insulin
(0.5
mg/kgBB/hari)
Insulin Basal
Insulin
Prandial
Yale Protocol (Insulin Drips)
Initial insulin
therapy (GDS 423):
Rapid-acting
insulin 5U / hour /
Syringe Pump
GDS 450-549 = 5 Units / hour / drips
GDS 350-449 = 4 Units / hour / drips
GDS 250-349 = 3 Units / hour / drips
GDS 150-249 = 2 Units / hour / drips
GDS 100-149 = 1 unit / hour / drips
-Target reduction in GDS from 50 to 100 mg / dL / hour
- If it does not reach the target, the dose is increased
50% from the initial dose.
- If the reduction in GDS is more than 100 mg / dL,
decrease the dose by 50% from the start.
- If GDS <80 stops insulin + bolus dextrose 40% 2
flacon (50 cc) in a 0.9% NACL infusion.
- If GDS 80-99 stops insulin + bolus dextrose 40%
25cc
Parameter Target
BMI (kg/m2) 18.5 - < 23*
Systolic Pressure (mmHg) < 140
Diastolic Pressure (mmHg) < 90
GDP (mg/dl) 80-130**
GD2PP (mg/dl) < 180**
HbA1c (%) < 7
LDL Cholesterol (mg/dl) < 100 or < 70 if
high risk for CVD
HDL Cholesterol (mg/dl) Men : > 40
Women: > 50
Trigliseride (mg/dl) < 150
*The Asia-Pacific Perspective: Redefining Obesity and Its
Treatment, 2000
**Standards of Medical Care in Diabetes, ADA 2015
Therapy
Goals
DM Complications
THANKYOU 

More Related Content

Similar to DIABETIC FOOT FFEAP (1).pptx

Acute on chronic hepatitis b
Acute on chronic hepatitis bAcute on chronic hepatitis b
Acute on chronic hepatitis bDondy Juliansyah
 
Duty report er 29th 2015
Duty report er 29th 2015Duty report er 29th 2015
Duty report er 29th 2015Soroy Lardo
 
Abdominal Pain with Choledecolhitasis
Abdominal Pain with CholedecolhitasisAbdominal Pain with Choledecolhitasis
Abdominal Pain with Choledecolhitasissoroylardo1
 
Hypoglycemia and ulcus and ck dduty report 13 jan 2016
Hypoglycemia and ulcus and ck dduty report 13 jan 2016Hypoglycemia and ulcus and ck dduty report 13 jan 2016
Hypoglycemia and ulcus and ck dduty report 13 jan 2016Soroy Lardo
 
Celiac common presentation of a uncommon disease saved with date
Celiac common presentation of a uncommon disease  saved with dateCeliac common presentation of a uncommon disease  saved with date
Celiac common presentation of a uncommon disease saved with dateMuhammad Arshad
 
Lupus nephritis
Lupus nephritisLupus nephritis
Lupus nephritisglyf26shai
 
Nephrotic syndrome case presentation
Nephrotic syndrome case presentationNephrotic syndrome case presentation
Nephrotic syndrome case presentationbinaya tamang
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndromeKAVIYA AP
 
Cholelithiasis case
Cholelithiasis caseCholelithiasis case
Cholelithiasis caseSharminLiza3
 
Lipoprotein glomerulopathy.pptx
Lipoprotein glomerulopathy.pptxLipoprotein glomerulopathy.pptx
Lipoprotein glomerulopathy.pptxPragnap7
 
Chronic Obstructive Pulmonary Disease Research.pdf
Chronic Obstructive Pulmonary Disease Research.pdfChronic Obstructive Pulmonary Disease Research.pdf
Chronic Obstructive Pulmonary Disease Research.pdfbkbk37
 
59229769 a-case-study-on-urinalysis-and-body-fluids
59229769 a-case-study-on-urinalysis-and-body-fluids59229769 a-case-study-on-urinalysis-and-body-fluids
59229769 a-case-study-on-urinalysis-and-body-fluidshomeworkping4
 
Case Presentation: Severe microcytic hypochromic iron deficiency anemia with ...
Case Presentation: Severe microcytic hypochromic iron deficiency anemia with ...Case Presentation: Severe microcytic hypochromic iron deficiency anemia with ...
Case Presentation: Severe microcytic hypochromic iron deficiency anemia with ...Dr. Afreen Nasir
 
Case report myelofibrosis
Case report myelofibrosisCase report myelofibrosis
Case report myelofibrosisSoroy Lardo
 

Similar to DIABETIC FOOT FFEAP (1).pptx (20)

Acute on chronic hepatitis b
Acute on chronic hepatitis bAcute on chronic hepatitis b
Acute on chronic hepatitis b
 
RPGN.pptx
RPGN.pptxRPGN.pptx
RPGN.pptx
 
Duty report er 29th 2015
Duty report er 29th 2015Duty report er 29th 2015
Duty report er 29th 2015
 
Abdominal Pain with Choledecolhitasis
Abdominal Pain with CholedecolhitasisAbdominal Pain with Choledecolhitasis
Abdominal Pain with Choledecolhitasis
 
Hypoglycemia and ulcus and ck dduty report 13 jan 2016
Hypoglycemia and ulcus and ck dduty report 13 jan 2016Hypoglycemia and ulcus and ck dduty report 13 jan 2016
Hypoglycemia and ulcus and ck dduty report 13 jan 2016
 
Celiac common presentation of a uncommon disease saved with date
Celiac common presentation of a uncommon disease  saved with dateCeliac common presentation of a uncommon disease  saved with date
Celiac common presentation of a uncommon disease saved with date
 
Alcohol & Amphetamines
Alcohol & AmphetaminesAlcohol & Amphetamines
Alcohol & Amphetamines
 
Lupus nephritis
Lupus nephritisLupus nephritis
Lupus nephritis
 
Case presentation on hepatits E
Case presentation on hepatits ECase presentation on hepatits E
Case presentation on hepatits E
 
Nephrotic syndrome case presentation
Nephrotic syndrome case presentationNephrotic syndrome case presentation
Nephrotic syndrome case presentation
 
Gouty Athritis , Cause of painful joints ,pseudo gout
Gouty Athritis , Cause of painful joints ,pseudo gout Gouty Athritis , Cause of painful joints ,pseudo gout
Gouty Athritis , Cause of painful joints ,pseudo gout
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndrome
 
Cholelithiasis case
Cholelithiasis caseCholelithiasis case
Cholelithiasis case
 
Lipoprotein glomerulopathy.pptx
Lipoprotein glomerulopathy.pptxLipoprotein glomerulopathy.pptx
Lipoprotein glomerulopathy.pptx
 
Chronic Obstructive Pulmonary Disease Research.pdf
Chronic Obstructive Pulmonary Disease Research.pdfChronic Obstructive Pulmonary Disease Research.pdf
Chronic Obstructive Pulmonary Disease Research.pdf
 
59229769 a-case-study-on-urinalysis-and-body-fluids
59229769 a-case-study-on-urinalysis-and-body-fluids59229769 a-case-study-on-urinalysis-and-body-fluids
59229769 a-case-study-on-urinalysis-and-body-fluids
 
Probable dengue
Probable dengueProbable dengue
Probable dengue
 
Ewing Sarcoma.pptx
Ewing Sarcoma.pptxEwing Sarcoma.pptx
Ewing Sarcoma.pptx
 
Case Presentation: Severe microcytic hypochromic iron deficiency anemia with ...
Case Presentation: Severe microcytic hypochromic iron deficiency anemia with ...Case Presentation: Severe microcytic hypochromic iron deficiency anemia with ...
Case Presentation: Severe microcytic hypochromic iron deficiency anemia with ...
 
Case report myelofibrosis
Case report myelofibrosisCase report myelofibrosis
Case report myelofibrosis
 

Recently uploaded

AIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.pptAIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.pptNishitharanjan Rout
 
Graduate Outcomes Presentation Slides - English (v3).pptx
Graduate Outcomes Presentation Slides - English (v3).pptxGraduate Outcomes Presentation Slides - English (v3).pptx
Graduate Outcomes Presentation Slides - English (v3).pptxneillewis46
 
TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT TOÁN 2024 - TỪ CÁC TRƯỜNG, TRƯỜNG...
TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT TOÁN 2024 - TỪ CÁC TRƯỜNG, TRƯỜNG...TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT TOÁN 2024 - TỪ CÁC TRƯỜNG, TRƯỜNG...
TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT TOÁN 2024 - TỪ CÁC TRƯỜNG, TRƯỜNG...Nguyen Thanh Tu Collection
 
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...EADTU
 
Đề tieng anh thpt 2024 danh cho cac ban hoc sinh
Đề tieng anh thpt 2024 danh cho cac ban hoc sinhĐề tieng anh thpt 2024 danh cho cac ban hoc sinh
Đề tieng anh thpt 2024 danh cho cac ban hoc sinhleson0603
 
Book Review of Run For Your Life Powerpoint
Book Review of Run For Your Life PowerpointBook Review of Run For Your Life Powerpoint
Book Review of Run For Your Life Powerpoint23600690
 
SURVEY I created for uni project research
SURVEY I created for uni project researchSURVEY I created for uni project research
SURVEY I created for uni project researchCaitlinCummins3
 
How To Create Editable Tree View in Odoo 17
How To Create Editable Tree View in Odoo 17How To Create Editable Tree View in Odoo 17
How To Create Editable Tree View in Odoo 17Celine George
 
OSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsOSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsSandeep D Chaudhary
 
When Quality Assurance Meets Innovation in Higher Education - Report launch w...
When Quality Assurance Meets Innovation in Higher Education - Report launch w...When Quality Assurance Meets Innovation in Higher Education - Report launch w...
When Quality Assurance Meets Innovation in Higher Education - Report launch w...Gary Wood
 
會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文
會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文
會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文中 央社
 
PSYPACT- Practicing Over State Lines May 2024.pptx
PSYPACT- Practicing Over State Lines May 2024.pptxPSYPACT- Practicing Over State Lines May 2024.pptx
PSYPACT- Practicing Over State Lines May 2024.pptxMarlene Maheu
 
DEMONSTRATION LESSON IN ENGLISH 4 MATATAG CURRICULUM
DEMONSTRATION LESSON IN ENGLISH 4 MATATAG CURRICULUMDEMONSTRATION LESSON IN ENGLISH 4 MATATAG CURRICULUM
DEMONSTRATION LESSON IN ENGLISH 4 MATATAG CURRICULUMELOISARIVERA8
 
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...Nguyen Thanh Tu Collection
 
e-Sealing at EADTU by Kamakshi Rajagopal
e-Sealing at EADTU by Kamakshi Rajagopale-Sealing at EADTU by Kamakshi Rajagopal
e-Sealing at EADTU by Kamakshi RajagopalEADTU
 
Improved Approval Flow in Odoo 17 Studio App
Improved Approval Flow in Odoo 17 Studio AppImproved Approval Flow in Odoo 17 Studio App
Improved Approval Flow in Odoo 17 Studio AppCeline George
 

Recently uploaded (20)

AIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.pptAIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.ppt
 
Graduate Outcomes Presentation Slides - English (v3).pptx
Graduate Outcomes Presentation Slides - English (v3).pptxGraduate Outcomes Presentation Slides - English (v3).pptx
Graduate Outcomes Presentation Slides - English (v3).pptx
 
TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT TOÁN 2024 - TỪ CÁC TRƯỜNG, TRƯỜNG...
TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT TOÁN 2024 - TỪ CÁC TRƯỜNG, TRƯỜNG...TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT TOÁN 2024 - TỪ CÁC TRƯỜNG, TRƯỜNG...
TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT TOÁN 2024 - TỪ CÁC TRƯỜNG, TRƯỜNG...
 
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
 
Đề tieng anh thpt 2024 danh cho cac ban hoc sinh
Đề tieng anh thpt 2024 danh cho cac ban hoc sinhĐề tieng anh thpt 2024 danh cho cac ban hoc sinh
Đề tieng anh thpt 2024 danh cho cac ban hoc sinh
 
Book Review of Run For Your Life Powerpoint
Book Review of Run For Your Life PowerpointBook Review of Run For Your Life Powerpoint
Book Review of Run For Your Life Powerpoint
 
SURVEY I created for uni project research
SURVEY I created for uni project researchSURVEY I created for uni project research
SURVEY I created for uni project research
 
How To Create Editable Tree View in Odoo 17
How To Create Editable Tree View in Odoo 17How To Create Editable Tree View in Odoo 17
How To Create Editable Tree View in Odoo 17
 
OSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsOSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & Systems
 
Mattingly "AI and Prompt Design: LLMs with NER"
Mattingly "AI and Prompt Design: LLMs with NER"Mattingly "AI and Prompt Design: LLMs with NER"
Mattingly "AI and Prompt Design: LLMs with NER"
 
When Quality Assurance Meets Innovation in Higher Education - Report launch w...
When Quality Assurance Meets Innovation in Higher Education - Report launch w...When Quality Assurance Meets Innovation in Higher Education - Report launch w...
When Quality Assurance Meets Innovation in Higher Education - Report launch w...
 
會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文
會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文
會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文
 
PSYPACT- Practicing Over State Lines May 2024.pptx
PSYPACT- Practicing Over State Lines May 2024.pptxPSYPACT- Practicing Over State Lines May 2024.pptx
PSYPACT- Practicing Over State Lines May 2024.pptx
 
Including Mental Health Support in Project Delivery, 14 May.pdf
Including Mental Health Support in Project Delivery, 14 May.pdfIncluding Mental Health Support in Project Delivery, 14 May.pdf
Including Mental Health Support in Project Delivery, 14 May.pdf
 
DEMONSTRATION LESSON IN ENGLISH 4 MATATAG CURRICULUM
DEMONSTRATION LESSON IN ENGLISH 4 MATATAG CURRICULUMDEMONSTRATION LESSON IN ENGLISH 4 MATATAG CURRICULUM
DEMONSTRATION LESSON IN ENGLISH 4 MATATAG CURRICULUM
 
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
 
e-Sealing at EADTU by Kamakshi Rajagopal
e-Sealing at EADTU by Kamakshi Rajagopale-Sealing at EADTU by Kamakshi Rajagopal
e-Sealing at EADTU by Kamakshi Rajagopal
 
VAMOS CUIDAR DO NOSSO PLANETA! .
VAMOS CUIDAR DO NOSSO PLANETA!                    .VAMOS CUIDAR DO NOSSO PLANETA!                    .
VAMOS CUIDAR DO NOSSO PLANETA! .
 
Improved Approval Flow in Odoo 17 Studio App
Improved Approval Flow in Odoo 17 Studio AppImproved Approval Flow in Odoo 17 Studio App
Improved Approval Flow in Odoo 17 Studio App
 
ESSENTIAL of (CS/IT/IS) class 07 (Networks)
ESSENTIAL of (CS/IT/IS) class 07 (Networks)ESSENTIAL of (CS/IT/IS) class 07 (Networks)
ESSENTIAL of (CS/IT/IS) class 07 (Networks)
 

DIABETIC FOOT FFEAP (1).pptx

  • 1. + DIABETIC FOOT - CASE REPORT DIVISI ENDOKRIN METABOLIK BAGIAN ILMU PENYAKIT DALAM UNIVERSITAS HASANUDDIN
  • 2. + Case  Name : Ny. M  Date of birth : 12-04-1969 / 40 years old  Gender : Female  Marital status : Married  Religion : Muslim  Address : Benteng, Wara Timur  Medical Record Number : 010430  Date of Admission : 28-10- 2019
  • 3. + History Taking The patient notice a spontaneous small opening and redness without any external injury on the dorsal and plantar aspect of left foot 2 weeks prior to admission. Wound was painfull, swelling and spreading. Currently there is mild discharge on the wound without foul smell. History of intermittent fever, nausea, vomiting, cough, difficulty in breathing and sleeplessness was present. There was history of amputation of little finger of the left hand a year ago due to ischemic and heel of right foot in 2012. Chief complaint: Injury of left foot
  • 4. + History Taking  She was diagnosed with Type 2 Diabetes Mellitus 10 years ago, uncontrol.  There’s no history and current impaired vision,  She was diagnosed with hyperurecemia, uncontrol.  The patient denied any history of heart disease, hypertention, hypercholestrolemia.  There is no history of cigarette smoking.
  • 5. + Patient Status General condition : Moderate Illness/Compos Mentis (E4M6V5) Height : 159 cm Weight : 53 kg BMI : 23.34 kg/m2 Vital Sign Blood pressure : 120/70 mmHg Heart rate : 75 x/minutes Respiratory rate : 18 x/minutes Temperature : 37,3 ‘C Physical Examination
  • 6. + Physical Examination Head • Shape : Normocephal •Face : Symmetrical left = right •Deformity : - Eye • Eksoptalmus/Enoptalmus : (-) • Movement : In normal range • Eyelid : Edema palpebra (-) • Conjungtiva : anemis • Sclera : Ikterik (-) • Cornea : Clear • Pupil : Isochore Φ2,5 mm/2,5 mm Ear • Hearing : In normal range • hemorrhage (-), Otorrhea (-)  Nose • Epistaxis : (-) • Nasal Discharge : (-) Mouth • Lip : Cyanosis (-), Dry (-) • Teeth : Dental caries (-) • Gumes : Bleeding gum (-) • Tonsil : T1 – T1, hyperemia (-) • Pharynx : Hiperemis (-) • Tongue : Dirty (-), Tremor(-), Hyperemia(-)
  • 7. + Physical Examination Neck Lymph nodes : Enlargement (-) Thyroid Gland : Enlargement (-) JVP : R+ 2 cm H2O Blood Vessels : In normal Range Nuchal Rigidity : Negatif Tumor : Negatif Trachea : Deviation (-) Toraks Inspection : Symetrical left = right Palpation : mass (-), vocal fremitus is normal Percussion: Sonor Auscultation: breath sound : vesicular. Ronchi and wheezing (-)
  • 8. + Physical Examination Cor Inspection: Ictus cordis isn’t visible Palpation : Ictus cordis isn’t palpable, Thrill (-), Tenderness (-) Percussion : Right Upper border 2nd ICS linea parasternalis dextra Left Upper border 3th ICS llinea parasternalis sinistra Right lower border 4th ICS linea parasternalis dextra Left lower border 6th ICS linea axillaris anterior sinistra Auscultation: Heart sound I/II pure regular, murmur (- ) Abdomen Inspection : convex, following breath movement Auscultation: Peristaltic sound (+), normal Palpation : Mass (-), tenderness (-), there are no palpable Percussion : Timpani (+), ascites (-)
  • 9. + Physical Examination Lower extremities Inspection : Ulcer on the left little toe 1x1cm. Gangrene on the left fourth and little toes (plantar pedis). Pus (-) , blood (-). Palpation : Tenderness Upper extremities Inspection : Amputated left little finger. Palpation : Tenderness (-)
  • 10. +
  • 11. + Laboratorium (08/05/2019) Examination Result Normal value RBC 2,28 (106/ mm3) F: 4.00 - 5.50 106/ mm3 M: 5.00 - 5.80 106/ mm3 HGB 6.9 (g/dL) 12.0 - 16.0 g/dL MCV 87.3 fL 80,0 – 97,0 Fl MCH 30.3 Pg 26.5 – 33,5 pg MCHC 34.7 (g/dL) 31.5 - 35.0 g/dL WBC 19.60 (103/uL) 4.00 - 10.0 103/uL NEUT 86.6 % 52.0 - 75.0 % LYMP 8.8 % 20.0 - 40.0 % PLT 375 (103/uL) 150 - 450 103/uL GDS 523 <140 mg/dL
  • 12. + Laboratorium (08/05/2019) Examination Result Normal Value RBC 2.66 (106/ mm3) F: 4.00 - 5.50 106/ mm3 M: 5.00 - 5.80 106/ mm3 HGB 8.1 (g/dL) 12.0 - 16.0 g/dL MCV 88.7 fL 80,0 – 97,0 fL MCH 30.5 Pg 26.5 – 33,5 pg MCHC 34.3 (g/dL) 31.5 - 35.0 g/dL WBC 22.16 (103/uL) 4.00 - 10.0 103/uL NEUT 84.1 % 52.0 - 75.0 % LYMP 8.8 % 20.0 - 40.0 % MONO 6.2 % 2.0 - 8.0 % EOS 0.8 % 1,00– 3.00% BASO 0.1 % 0.0 - 0.10 % HCT 23.6 % 37.0 - 48.0 % PLT 357 (103/uL) 150 - 450 103/uL
  • 13. + Examination Result Normal value GDS 350 <140 mg/dL SGPT 21 <41 SGOT 15 <38 U/L Albumin - 3,5-5,0 gr/dl Kreatinin 1.5 M<1,3; F<1,1 Ureum 33 10-50 mg/dl Natrium 136 136-145 Kalium 4.3 3,5-5,1 Klorida 106 97-111 PT 15.5 10-14 Second INR 1.3 -- APTT 26.4 22,0-30,0 Second
  • 14. Assesment 1. Diabetic Foot wagner IV Pedis Sinistra 2. Diabetes Militus Type 2 Non Obest 3. Anemia Normocytic Normochrome 4. Diabetic Gastropathy
  • 15. Therapy • Infusion NaCl 0,9% 30 TPM • Novorapid 18-18-18 sc • Levemir 0-0-20 sc • Paracetamol 1g/8 Hour/Intravena • Ciprofloxacin 500mg/8 Hour/Intraven • Metronidazole 500g/8 Hour/ Intraven • Ceftriaxon 2gr/24hour/Intraven • Transfusion PRC 1 Bag • Omeprazole 20mg /12 Hour/Oral • Domperidone 10mg/8 hours/oral
  • 16. Planning • Blood Glucose Monitoring • Diet (Diet DM 1700 kkal) • Wound control • Radiology : X-ray pedis
  • 18. Definition • Diabetic foot is one of the most significant and devastating complications of diabetes, and is defined as a foot affected by ulceration that is associated with neuropathy and/or peripheral arterial disease of the lower limb in a patient with diabetes.
  • 19. Epidemiology • Systematic review included a large sample of studies involving more than 800,000 global participants from 67 studies in the past three decades. These studies included patients from five continents.suggested that the pooled prevalence of diabetic foot ulceration was about 6.3% worldwide • The results suggested that the highest prevalence of diabetic foot ulceration was reported in North Americ (13.0%), and the lowest prevalence was reported in Oceania (3.0%). The prevalence of diabetic foot ulcer was relatively higher in Africa (7.2%) than in Asia (5.5%) and Europe (5.1%). Zhang, P., 2017. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Annals of Medicine, 1, 1.
  • 20. Clinical Manifestasions Clinical manifestations of DM are associated with the metabolic consequences of insulin deficiency: • Fasting sugar levels are not normal. • Poliuria • Polidipsia • Polifagia • Weight Loss • Tired and sleepy • Other symptoms that are complained of are tingling, itching, blurred eyes, impotence in men, and prurity vulva in women.
  • 21. In addition, there are other clinical symptoms that show more signs of ulcers due to microangiopathy in people with diabetes mellitus, which is 5P which means: a. Pain(nyeri) b. Paleness(kepucatan) c. Paresthesia (kesemutan) d. Pulselessness (denyut nadi hilang) e. Paralysis (kelumpuhan) Clinical Symptoms
  • 26. The nylon monofilament test is a simply performed office test to diagnose patients at risk for ulcer formation due to peripheral sensory neuropathy. The test is abnormal if the patient cannot sense the touch of the monofilament when it is pressed against the foot with just enough pressure to bend the filament
  • 27. DM Therapy: Non Pharmacology •The course of the disease, the need for ongoing control and monitoring DM complications, risk factors, non-pharmacological interventions, pharmacological, and treatment targets How to monitor blood glucose and interpret the results, recognize early symptoms and manage hypoglycemia The importance of foot care and regular physical exercise Education •Cannot walk barefoot Check the foot every day, report to the doctor for skin peeling, redness, or sores Check footwear from foreign objects before use Keep feet clean Cut nails regularly Dry regularly after the bathroom Use cotton socks Thin the callus regularly Use custom made footwear Feet Care
  • 28. DM Therapy: Non Pharmacology KARBOHIDRAT •Karbohidrat: 45- 65%, berserat tinggi, tidak boleh & 130 g •Glukosa dalam bumbu masih diperbolehkan •Sukrosa &amp;lt; 5% •Pemanis alternatif •Makan tiga kali sehari + selingan LEMAK •20-25% (Lemak jenuh & 7%; lemak tidak jenuh ganda &amp;lt; 10%; selebihnya lemak tidak jenuh tunggal) •Batasi daging berlemak dan susu fullcream (lemak trans) •Konsumsi kolesterol &200 mg/hari PROTEIN •10-20% •Nefropati diabetik: 10% atau 0.8 g/kgBB dengan 65% diantaranya bernilai biologik tinggi •Penderita DM yang menjalani HD: 1-1.2 g/kgBB/hari NATRIUM •2300 mg/hari SERAT •20-35 g/hari •Kacang-kacangan, buah, dan sayuran, karbohidrat tinggi serat PEMANIS ALTERNATIF •Berkalori: Hitung kandungan kalorinya (isomalt, lactitol, maltitol, mannitol, sorbitol, xylitol) •Fruktosa tidak dianjurkan Meningkatkan kadar LDL. Namun tidak ada alasan menghindari makanan seperti buah/sayur karena mengandung fruktosa alami •Tak berkalori: Aspartam, sakarin, acesulfame potassium, sukralose, neotame
  • 29. DM Therapy: Non Pharmacology • 3-5 kali per minggu • 30-45 menit (total 150 menit per minggu) • Jeda antar latihan tidak lebih dari 2 hari berturut-turut • GDS &amp;lt; 100 mg/dl Konsumsi karbohidrat terlebih dahulu • GDS &amp;gt; 250 mg/dl Tunda olahraga • Latihan jasmani bersifat aerobik • Intensitas sedang • Jalan cepat • Bersepeda santai • Jogging • Berenang • DM tanpa kontraindikasi (OA, HT tidak terkontrol, retinopati, nefropati) • Resistance training (latihan beban) 2-3 kali/minggu Exercise
  • 32. Yale Protocol (Insulin Drips) Initial insulin therapy (GDS 423): Rapid-acting insulin 5U / hour / Syringe Pump GDS 450-549 = 5 Units / hour / drips GDS 350-449 = 4 Units / hour / drips GDS 250-349 = 3 Units / hour / drips GDS 150-249 = 2 Units / hour / drips GDS 100-149 = 1 unit / hour / drips -Target reduction in GDS from 50 to 100 mg / dL / hour - If it does not reach the target, the dose is increased 50% from the initial dose. - If the reduction in GDS is more than 100 mg / dL, decrease the dose by 50% from the start. - If GDS <80 stops insulin + bolus dextrose 40% 2 flacon (50 cc) in a 0.9% NACL infusion. - If GDS 80-99 stops insulin + bolus dextrose 40% 25cc
  • 33. Parameter Target BMI (kg/m2) 18.5 - < 23* Systolic Pressure (mmHg) < 140 Diastolic Pressure (mmHg) < 90 GDP (mg/dl) 80-130** GD2PP (mg/dl) < 180** HbA1c (%) < 7 LDL Cholesterol (mg/dl) < 100 or < 70 if high risk for CVD HDL Cholesterol (mg/dl) Men : > 40 Women: > 50 Trigliseride (mg/dl) < 150 *The Asia-Pacific Perspective: Redefining Obesity and Its Treatment, 2000 **Standards of Medical Care in Diabetes, ADA 2015 Therapy Goals
  • 34.